FAKTOR-OPTIONSSCHEIN - ROCHE GS Share Price

Certificat

DE000SV4XNR3

Market Closed - Deutsche Boerse AG 20:37:46 25/06/2024 BST
1.61 EUR +1.90% Intraday chart for FAKTOR-OPTIONSSCHEIN - ROCHE GS
Current month-70.07%
1 month-68.86%
Date Price Change
25/06/24 1.61 +1.90%
24/06/24 1.58 -9.20%
21/06/24 1.74 -11.22%
20/06/24 1.96 -3.92%
19/06/24 2.04 -10.13%

Delayed Quote Deutsche Boerse AG

Last update June 25, 2024 at 08:37 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SV4XNR
ISINDE000SV4XNR3
Date issued 03/05/2023
Strike 280.5 CHF
Maturity Unlimited
Parity 1 : 1
Emission price 10.41
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 32.62
Lowest since issue 1.57
Spread 0.03
Spread %1.70%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
253.4 CHF
Average target price
278.1 CHF
Spread / Average Target
+9.73%
Consensus